166 related articles for article (PubMed ID: 15517488)
1. Single center experience in primary surgery for medullary thyroid carcinoma.
Ukkat J; Gimm O; Brauckhoff M; Bilkenroth U; Dralle H
World J Surg; 2004 Dec; 28(12):1271-4. PubMed ID: 15517488
[TBL] [Abstract][Full Text] [Related]
2. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma.
Opsahl EM; Brauckhoff M; Schlichting E; Helset K; Svartberg J; Brauckhoff K; Mæhle L; Engebretsen LF; Sigstad E; Grøholt KK; Akslen LA; Jørgensen LH; Varhaug JE; Bjøro T
Thyroid; 2016 Sep; 26(9):1225-38. PubMed ID: 27400880
[TBL] [Abstract][Full Text] [Related]
3. Determinative factors of biochemical cure after primary and reoperative surgery for sporadic medullary thyroid carcinoma.
Gimm O; Ukkat J; Dralle H
World J Surg; 1998 Jun; 22(6):562-7; discussion 567-8. PubMed ID: 9597929
[TBL] [Abstract][Full Text] [Related]
4. Surgical strategy in a kindred with a rare RET protooncogene mutation of variable penetrance with regard to multiple endocrine neoplasia.
Colombo-Benkmann M; Brämswig J; Höppner W; Gellner R; Hengst K; Böcker W; Senninger N
World J Surg; 2002 Oct; 26(10):1286-90. PubMed ID: 12205548
[TBL] [Abstract][Full Text] [Related]
5. [Prophylactic thyroidectomy in children who are carriers of a multiple endocrine neoplasia type 2 mutation: description of 20 cases and recommendations based on the literature].
de Groot JW; Links TP; Rouwe CW; van der Wal JE; Hofstra RM; Plukker JT
Ned Tijdschr Geneeskd; 2006 Feb; 150(6):311-8. PubMed ID: 16503023
[TBL] [Abstract][Full Text] [Related]
6. When should thyroidectomy be performed in familial medullary thyroid carcinoma gene carriers with non-cysteine RET mutations?
Niccoli-Sire P; Murat A; Rohmer V; Gibelin H; Chabrier G; Conte-Devolx B; Visset J; Ronceray J; Jaeck D; Henry JF; Proye C; Carnaille B; Kraimps JL;
Surgery; 2003 Dec; 134(6):1029-36; discussion 1036-7. PubMed ID: 14668737
[TBL] [Abstract][Full Text] [Related]
7. Can We Predict the Lateral Compartment Lymph Node Involvement in RET-Negative Patients with Medullary Thyroid Carcinoma?
Chandeze MM; Noullet S; Faron M; Trésallet C; Godiris-Petit G; Tissier F; Buffet C; Leenhardt L; Chereau N; Menegaux F
Ann Surg Oncol; 2016 Oct; 23(11):3653-3659. PubMed ID: 27271930
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome of "prophylactic therapy" for familial medullary thyroid cancer.
Schellhaas E; König C; Frank-Raue K; Buhr HJ; Hotz HG
Surgery; 2009 Nov; 146(5):906-12. PubMed ID: 19744457
[TBL] [Abstract][Full Text] [Related]
9. Importance of early screening and prophylactic thyroidectomy in asymptomatic nonindex RET germline carriers.
Ukkat J; Lorenz K; Hinze R; Thomusch O; Dralle H
World J Surg; 2001 Jun; 25(6):713-7. PubMed ID: 11376404
[TBL] [Abstract][Full Text] [Related]
10. Sporadic hypercalcitoninemia: clinical and therapeutic consequences.
Scheuba C; Kaserer K; Moritz A; Drosten R; Vierhapper H; Bieglmayer C; Haas OA; Niederle B
Endocr Relat Cancer; 2009 Mar; 16(1):243-53. PubMed ID: 18987170
[TBL] [Abstract][Full Text] [Related]
11. Prospective trial of unilateral surgery for nonhereditary medullary thyroid carcinoma in patients without germline RET mutations.
Miyauchi A; Matsuzuka F; Hirai K; Yokozawa T; Kobayashi K; Ito Y; Nakano K; Kuma K; Futami H; Yamaguchi K
World J Surg; 2002 Aug; 26(8):1023-8. PubMed ID: 12016484
[TBL] [Abstract][Full Text] [Related]
12. Unilateral surgery supported by germline RET oncogene mutation analysis in patients with sporadic medullary thyroid carcinoma.
Miyauchi A; Matsuzuka F; Hirai K; Yokozawa T; Kobayashi K; Kuma S; Kuma K; Futami H; Yamaguchi K
World J Surg; 2000 Nov; 24(11):1367-72. PubMed ID: 11038208
[TBL] [Abstract][Full Text] [Related]
13. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
[TBL] [Abstract][Full Text] [Related]
14. Individualization of lymph node dissection in RET (rearranged during transfection) carriers at risk for medullary thyroid cancer: value of pretherapeutic calcitonin levels.
Machens A; Lorenz K; Dralle H
Ann Surg; 2009 Aug; 250(2):305-10. PubMed ID: 19638924
[TBL] [Abstract][Full Text] [Related]
15. Primary hereditary medullary thyroid carcinoma--C-cell morphology and correlation with preoperative calcitonin levels.
Hinze R; Holzhausen HJ; Gimm O; Dralle H; Rath FW
Virchows Arch; 1998 Sep; 433(3):203-8. PubMed ID: 9769122
[TBL] [Abstract][Full Text] [Related]
16. Surgical strategy for the treatment of medullary thyroid carcinoma.
Fleming JB; Lee JE; Bouvet M; Schultz PN; Sherman SI; Sellin RV; Friend KE; Burgess MA; Cote GJ; Gagel RF; Evans DB
Ann Surg; 1999 Nov; 230(5):697-707. PubMed ID: 10561095
[TBL] [Abstract][Full Text] [Related]
17. Video assisted prophylactic thyroidectomy and central compartment nodes clearance in two RET gene mutation adult carriers.
Miccoli P; Elisei R; Berti P; Materazzi G; Agate L; Castagna MG; Cosci B; Faviana P; Ugolini C; Pinchera A
J Endocrinol Invest; 2004 Jun; 27(6):557-61. PubMed ID: 15717653
[TBL] [Abstract][Full Text] [Related]
18. Complete surgical lymph node resection does not prevent authentic recurrences of medullary thyroid carcinoma.
Franc S; Niccoli-Sire P; Cohen R; Bardet S; Maes B; Murat A; Krivitzky A; Modigliani E;
Clin Endocrinol (Oxf); 2001 Sep; 55(3):403-9. PubMed ID: 11589685
[TBL] [Abstract][Full Text] [Related]
19. Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer.
Scollo C; Baudin E; Travagli JP; Caillou B; Bellon N; Leboulleux S; Schlumberger M
J Clin Endocrinol Metab; 2003 May; 88(5):2070-5. PubMed ID: 12727956
[TBL] [Abstract][Full Text] [Related]
20. Reoperation in metastasizing medullary thyroid carcinoma: is a tumor stage-oriented approach justified?
Gimm O; Dralle H
Surgery; 1997 Dec; 122(6):1124-30; discussion 1130-1. PubMed ID: 9426428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]